Silo Pharma: Meet the team bridging the gap between traditional pharmaceuticals and psychedelic therapies

Silo Pharma Inc (OTCMKTS:SILO) will be presenting with Lobe Sciences Ltd (CSE:LOBE) (OTCMKTS: (GTSIF) at Proactive’s next virtual showcase event on February 23.

The psychedelic-themed event will be hosted by Proactive’s Christine Corrado and kicks off on Tuesday at 1 PM ET.

SIGN-UP: Proactive One2One February 2

Silo Pharma is bridging the gap between traditional pharmaceuticals and the emerging psychedelics space.

The developmental-stage biopharmaceutical company’s mission is to identify assets to license and fund the research which it believes could transform both the well-being of patients and the healthcare system at large.

“In these uncertain times, the mental health of the nation and beyond is being put to the test. More than ever, creative new therapies and lines of thought are needed to address health challenges of today,” Silo writes. “Combining our resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.”

The company’s management and founders have played key roles in numerous successful biotech companies. CEO Eric Weisblum will share the company’s story and strategies for success at Tuesday’s event.

CLICK HERE TO REGISTER

Story by ProactiveInvestors